148 related articles for article (PubMed ID: 1444110)
1. [Polyvalent intravenous immunoglobulins: their use in dermatology].
Derancourt C; Humbert P; Agache P
Ann Dermatol Venereol; 1992; 119(6-7):487-8. PubMed ID: 1444110
[No Abstract] [Full Text] [Related]
2. Dermatological uses of high-dose intravenous immunoglobulin.
Jolles S; Hughes J; Whittaker S
Arch Dermatol; 1998 Jan; 134(1):80-6. PubMed ID: 9449914
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience.
Wetter DA; Davis MD; Yiannias JA; Gibson LE; Dahl MV; el-Azhary RA; Bruce AJ; Lookingbill DP; Ahmed I; Schroeter AL; Pittelkow MR
Mayo Clin Proc; 2005 Jan; 80(1):41-7. PubMed ID: 15667028
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchanges in the treatment of skin disease.
Roujeau JC; Fabre M; Noel L
Int J Artif Organs; 1982 Jul; 5(4):257-60. PubMed ID: 6126439
[No Abstract] [Full Text] [Related]
6. Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.
Forbat E; Ali FR; Al-Niaimi F
Clin Exp Dermatol; 2018 Aug; 43(6):659-666. PubMed ID: 29774587
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
8. [Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases].
De Vita S; D'Ascanio A; Bombardieri S
Recenti Prog Med; 1991 Nov; 82(11):603-6. PubMed ID: 1763234
[TBL] [Abstract][Full Text] [Related]
9. [Kawasaki syndrome in adults: treatment with polyvalent intravenous immunoglobulins].
Pavese P; Brion JP; Meusnier T; Stahl JP
Ann Med Interne (Paris); 1997; 148(3):287-8. PubMed ID: 9255342
[No Abstract] [Full Text] [Related]
10. [Effect of hemosorption on the course of autoimmune diseases with predominant involvement of the skin].
Dmitriev AA; Ivanova MM; Ivanov OL; Khapilova VI
Klin Med (Mosk); 1982 Mar; 60(3):93-7. PubMed ID: 7087387
[No Abstract] [Full Text] [Related]
11. [What is new in American dermatology].
Hollander A
Hautarzt; 1968 Aug; 19(8):337-45. PubMed ID: 4878767
[No Abstract] [Full Text] [Related]
12. [Dexamethasone; a new corticosteroid].
MOM AM
Dia Med; 1958 Dec; 30(94):3267 passim. PubMed ID: 13630158
[No Abstract] [Full Text] [Related]
13. [Facultative paraneoplasia of the skin].
Blum A; Grossmann S; Röhm S; Röcken M
Dtsch Med Wochenschr; 2003 Oct; 128(43):2257-60. PubMed ID: 14574640
[No Abstract] [Full Text] [Related]
14. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
15. [Indications for intravenous immunoglobulins].
Mouthon L
Presse Med; 2006 Apr; 35(4 Pt 2):714-9. PubMed ID: 16614620
[TBL] [Abstract][Full Text] [Related]
16. Periodontal implications: mucocutaneous disorders.
J Am Dent Assoc; 1998 Sep; 129 Suppl():29S-31S. PubMed ID: 9766119
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin therapy: magic or black magic.
Barron KS; Sher MR; Silverman ED
J Rheumatol Suppl; 1992 Apr; 33():94-7. PubMed ID: 1593608
[TBL] [Abstract][Full Text] [Related]
18. [Plasma exchange therapy in dermatologic diseases. Review of literature and personal experiences in psoriasis vulgaris].
Klemm-Mayer H; Sterry W; Borberg H
Z Hautkr; 1983 Aug; 58(15):1085-94. PubMed ID: 6356661
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
Migliaresi S; Gallo M; Tirri G
Clin Ter; 1992 Sep; 141(9 Pt 2):83-4. PubMed ID: 1468203
[TBL] [Abstract][Full Text] [Related]
20. [Bullous diseases and their monitoring at the dermatology clinic].
Rozsívalová V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1987; 30(5):687-94. PubMed ID: 3333100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
